Skip to Content (press ENTER)

Published Research

View more on Harvard Catalyst

  1. Wang QM, Stalker TJ, Gong Y, Rikitake Y, Scalia R, Liao JK. Inhibition of Rho kinase attenuates endothelial-leukocyte interaction during ischemic-reperfusion injury. Vasc Med 2012;17:379-385.
  2. Wang QM, Liao JK. ROCKs as immunomodulators of stroke. Expert Opin Ther Targets 2012;16: 1013-1025.
  3. Wang QM, Wei Y, Zheng Y, Waeber C. Efficacy of combined atorvastatin and sildenafil in promoting recovery after ischemic stroke in mice. Am J Phys Med Rehabil 2013; 92:143-150.
  4. Zee RYL*, Wang QM*, Chasman DI, Ridker PM and Liao JK. Gene variations of ROCKs and risk of ischemic stroke: The Women’s Genome Health Study. Clinical Science. 2014; 126: 829-835. R. Zee and Q. Wang contributed equally to this study.
  5. Wang QM, Cui H, Han SJ, Black-Schaffer R, Volz M, Lee YT, Herman S, Latif LA, Zafonte R and Fregni F. Combination of transcranial direct current stimulation and methylphenidate in subacute stroke. Neurosci Lett 2014; 569: 6-11.
  6. Liu X, Kenkare K, Desai V, Li S, Wong J, Luo X, Wood L, Yu X, Wang QM*. Increased Th17/Treg ratio in post-stroke fatigue. Mediators of inflammation, June 2015.
  7. Wen H, Alshikho M, Wang Y, Luo X, Zafonte R, Herbert M, Wang QM*. Correlation of fractional anisotropy with motor recovery in stroke patients following acute rehabilitation. Archive PMR, May, 2016.
  8. Liu T, Wang X, Tang X, Gong T, Ye W, Pan C, Ding H, Luo X, Li X, and Wang QM*. Surface Modification with ECM-Inspired SDF-1α/Laminin-loaded nanocoating for vascular wound healing. Applied Materials and Interface, 2017, 9, 30373−30386
  9. Liu T, Li X, Liu S, Tang, X, Wang, X, Gong, T, Hu, Y, Ding, H, Luo, X, Pan, C, Wang, QM*. Surface Modification with Micropatterned Heparin/Poly-L-Lysine nanoparticles to direct platelet and Endothelial Cell Behavior. Journal of Biomaterials and Tissue Engineering, October 7, 2017 (962-968)
  10.   Pinto CB, Velez FGB, Lopes F, Piza RVT, Dipietro L, Wang QM, Mazwi NL, Camargo ED, Black-Schaffer RM, Fregni F. Selective serotonin reuptake inhibitors and motor recovery in stroke: reestablishment of inhibitory neural network tonus. Frontiers in Neuroscience, 2017, Nov 16, 11:637 doi 10.3389/fnins.2017.00637
  11.   Li S, Wang Y, Jiang Z, Huai Y, Liao JK, Lynch KA, Zafonte R, Wood LJ and Wang QM*. Impaired Cognitive Performance in Endothelial Nitric Oxide Synthase Knockout Mice after Ischemic Stroke, A Pilot Study. AJPMR, 2018, 97(7):492-499
  12.   Huang J, Liu X, Luo X, Tang C, Xu M, Wood L, Wang Y, Wang QM*. Effects of fluoxetine on poststroke dysphagia: A clinical retrospective study. Journal of Stroke and Cerebrovascular Diseases, Vol 27, No 11 (Nov) 2018; 3320-3327
  13.   Luo W, Liu T, Li S, Wen H, Zhou F, Zafonte R, Luo X, Xu M, Black-Schaffer R, Wood LJ, Wang Y, Wang QM*. The Serum BDNF Level Offers Minimum Predictive Value for Motor Function Recovery After Stroke. Trans Stroke Res, 2018, Aug 3. doi: 10.1007/s12975-018-0648-5
  14.   Cui S, Xu M, Huang J, Wang QM, Lai X, Nie B, Shan B, Luo X, Wong J and Tang C. Cerebral responses to acupuncture at GV24 and bilateral GB13 in rat model of Alzheimer’s disease. Behav Neurol. 2018: 8740284
  15.   Wen H, Weymann KB, Wood L, Wang QM*. Inflammatory signaling in post-stroke fatigue and depression. Eur Neurol. 2018;80(3-4):138-148. doi: 10.1159/000494988.
  16.   Bonin CP, Quezada JL, Piza P, Zeng D, Velz F, Ferreira IS, Lucena PH, Duarte D, Lopes F, El-Hagrassy M, Rizzo LV, Camargo, EC, Lin DJ, Mazwi M, Wang QM, Black-Schaffer RM, Fregni F.Combining Fluoxetine and rTMS in Poststroke Motor Recovery: A Placebo-Controlled Double-Blind Randomized Phase 2 Clinical Trial. Neurorehabilitation and neural repair 33(8):154596831986048 · July 2019
  17. . Han Z, Qi, L, Xu Q, Xu M, Cai L, Wong J, Hu X, Luo X, Wang J, Zhang Y, Li Y, Wang QM* BDNF Met Allele is associated with lower cognitive function in post-stroke rehabilitation. Neurorehabilitation and Neural Repair, March 2020
  18.  Wang X, Liu T, Song H, Cui S, Liu G, Christoforou A, Flaherty P, Luo X, Wood L, Wang QM*. Targeted metabolomic profiling reveals association between altered amino acids and poor functional recovery after stroke. Frontiers Neurology 10: 1425, Jan 2020